HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Microbiome Approval Pathway Workshop Could Help Sort Out Probiotic Path

This article was originally published in The Rose Sheet

Executive Summary

FDA's regulatory pathway "for development of probiotic drugs is reasonably clear. But the road to develop probiotic foods, supplements or microbiome-based dietary strategies to compensate for deficient microbiota is less so," says the International Scientific Association for Probiotics and Prebiotics. FDA's Center for Biologics Evaluation and Research is conducting Sept. 17 workshop to exchange information with the scientific community about the clinical, manufacturing and regulatory considerations associated with live microbiome-based products administered to treat a disease.

You may also be interested in...



Kyowa Hakko Expands Probiotic Supplies With ‘Dead’ Ingredient To Battle Eye Fatigue

Kyowa Hakko unveils supplement ingredient Eyemuse, a heat-treated “paraprobiotic” found to reduce eye fatigue, filter blue light and support a balanced immune response. CRN campaign educates retailers, consumers about probiotics and helps retailers improve handling of the products.

Pandemic Driving Stress In Consumers? DuPont Has A Probiotic Strain For That

HOWARU Calm contains probiotic strain Lpc-37 (L. paracasei) and can be added to supplements or formulated into new products, says DuPont Nutrition & Biosciences. It reports that 65% of adults worldwide are experiencing some daily stress.

DuPont Sees Immune Health Probiotic Sales Opening Window On More Microbial Use In Nutrition

While stockpiling for immune health support drove early sales growth in response to the pandemic, probiotic sales likely will continue increasing, says DuPont Nutrition probiotic marketing head Vanessa Bailey. “My gut tells me I think we could see some sustained increase. There’s going to be some difference in how we behave.”

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS121799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel